Josette F. Briere
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Lymphoproliferative disorders and lymphomas in immunocompromised patients
Journal: Annales de pathologie
Published: December 02, 2025
Case #2. High-grade B-cell lymphoma with 11q aberration: A case report
Journal: Annales de pathologie
Published: November 24, 2025
Early Positron Emission Tomography Response-Adapted Treatment in Low-Risk Diffuse Large B-Cell lymphoma: an open label, multicenter, randomised, non-inferiority phase 3 trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 20, 2025
Early positron emission tomography response-adapted treatment in low-risk diffuse large B-cell lymphoma: an open-label, multicenter, randomized, noninferiority phase III trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 20, 2025
Follicular Helper T-cell Lymphoma With Hodgkin/Reed-Sternberg-Like Cells Versus Classic Hodgkin Lymphoma: A Comparative Study.
Journal: The American journal of surgical pathology
Published: January 06, 2025
Multimodal integration of clinic, pathology, and genomics for a rare diagnosis of EBV-positive primary mediastinal large B-cell lymphoma.
Journal: Virchows Archiv : an international journal of pathology
Published: February 27, 2024
MYC Rearrangement Prediction From LYSA Whole Slide Images in Large B-Cell Lymphoma: A Multicentric Validation of Self-supervised Deep Learning Models.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: December 13, 2023
Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients: A LYSA group study.
Journal: British journal of haematology
Published: October 17, 2022
ALK+ large B cell lymphoma presenting as multiple bowel-obstructing, cytokeratin-positive tumours.
Journal: Histopathology
Published: December 20, 2021
Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA.
Journal: Blood
Published: August 19, 2020
Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials.
Journal: Cancer medicine
Published: April 07, 2020
Last Updated: 09/26/2026